RENB Stock Summary and Trading Ideas (Renovaro | NASDAQ:RENB)

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Renovaro trades on the NASDAQ stock market under the symbol RENB.

As of December 12, 2024, RENB stock price declined to $1.72 with 721,165 million shares trading.

RENB has a beta of 2.69, meaning it tends to be more sensitive to market movements. RENB has a correlation of 0.03 to the broad based SPY ETF.

RENB has a market cap of $272.99 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that RENB belongs to (by Net Assets): IWM, VTI, VXF, IWO, IWN.

RENB has underperformed the market in the last year with a return of -52.6%, while SPY returned +32.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RENB shares. However, RENB has outperformed the market in the last 3 month and 2 week periods, returning +163.6% and +181.8%, while SPY returned +9.3% and +0.9%, respectively. This indicates RENB has been having a stronger performance recently.

RENB support price is $1.64 and resistance is $2.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RENB shares will trade within this expected range on the day.